Differential expression of hypoxia-inducible factors related to the invasiveness of epithelial ovarian cancer
Authors:
Open Access
- 25 November 2021
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-13
Abstract
Ovarian cancer is the most lethal gynecological cancer, and it is frequently diagnosed at advanced stages, with recurrences after treatments. Treatment failure and resistance are due to hypoxia-inducible factors (HIFs) activated by cancer cells adapt to hypoxia. IGFBP3, which was previously identified as a growth/invasion/metastasis suppressor of ovarian cancer, plays a key role in inhibiting tumor angiogenesis. Although IGFBP3 can effectively downregulate tumor proliferation and vasculogenesis, its effects are only transient. Tumors enter a hypoxic state when they grow large and without blood vessels; then, the tumor cells activate HIFs to regulate cell metabolism, proliferation, and induce vasculogenesis to adapt to hypoxic stress. After IGFBP3 was transiently expressed in highly invasive ovarian cancer cell line and heterotransplant on mice, the xenograft tumors demonstrated a transient growth arrest with de-vascularization, causing tumor cell hypoxia. Tumor re-proliferation was associated with early HIF-1α and later HIF-2α activations. Both HIF-1α and HIF-2α were related to IGFBP3 expressions. In the down-expression of IGFBP3 in xenograft tumors and transfectants, HIF-2α was the major activated protein. This study suggests that HIF-2α presentation is crucial in the switching of epithelial ovarian cancer from dormancy to proliferation states. In highly invasive cells, the cancer hallmarks associated with aggressiveness could be activated to escape from the growth restriction state.Keywords
Funding Information
- National Taiwan University Hospital (102-S2191 and 104-S2737)
This publication has 50 references indexed in Scilit:
- Bevacizumab and ovarian cancerTherapeutic Advances in Medical Oncology, 2012
- Hypoxia induces IGFBP3 in esophageal squamous cancer cells through HIF‐1α‐mediated mRNA transcription and continuous protein synthesisThe FASEB Journal, 2012
- Opposite effects of HIF-1α and HIF-2α on the regulation of IL-8 expression in endothelial cellsFree Radical Biology and Medicine, 2011
- Up-regulation of glyceraldehyde-3-phosphate dehydrogenase gene expression by HIF-1 activity depending on Sp1 in hypoxic breast cancer cellsArchives of Biochemistry and Biophysics, 2011
- Oncogenic KRAS modulates mitochondrial metabolism in human colon cancer cells by inducing HIF-1α and HIF-2α target genesMolecular Cancer, 2010
- Promoter methylation of IGFBP-3 and p53 expression in ovarian endometrioid carcinomaMolecular Cancer, 2009
- HIF2α inhibition promotes p53 pathway activity, tumor cell death, and radiation responsesProceedings of the National Academy of Sciences, 2009
- Regulation of cancer cell metabolism by hypoxia-inducible factor 1Seminars in Cancer Biology, 2009
- Hypoxia inducible factor-2α: a critical mediator of aggressive tumor phenotypesCurrent Opinion in Genetics & Development, 2009
- Perivenous expression of the mRNA of the three hypoxia-inducible factor α-subunits, HIF1α, HIF2α and HIF3α, in rat liverBiochemical Journal, 2001